Follow the Lixte Biotechnology Holdings, INC. share price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Operating in the Health Care sector, Lixte Biotechnology Holdings, INC. has logged 15 public disclosures. Market capitalisation: €57.2m. The latest transaction was reported on 5 October 2023 (Acquisition). Among the most active insiders: FORMAN ERIC. Every trade is free.
15
Insider Decl.
0
Thresholds
€147,061
13 ops.
Buy Volume
·
0 ops.
Sell Volume
45Σ signal
Buys €147,061· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.